Evaluation of sex differences in dietary behaviours and their relationship with cardiovascular risk factors: a cross-sectional study of nationally representative surveys in seven low- and middle-income countries.


Journal

Nutrition journal
ISSN: 1475-2891
Titre abrégé: Nutr J
Pays: England
ID NLM: 101152213

Informations de publication

Date de publication:
13 01 2020
Historique:
received: 02 10 2019
accepted: 23 12 2019
entrez: 14 1 2020
pubmed: 14 1 2020
medline: 11 3 2021
Statut: epublish

Résumé

Cardiovascular diseases (CVD) are the leading causes of death for men and women in low-and-middle income countries (LMIC). The nutrition transition to diets high in salt, fat and sugar and low in fruit and vegetables, in parallel with increasing prevalence of diet-related CVD risk factors in LMICs, identifies the need for urgent action to reverse this trend. To aid identification of the most effective interventions it is crucial to understand whether there are sex differences in dietary behaviours related to CVD risk. From a dataset of 46 nationally representative surveys, we included data from seven countries that had recorded the same dietary behaviour measurements in adults; Bhutan, Eswatini, Georgia, Guyana, Kenya, Nepal and St Vincent and the Grenadines (2013-2017). Three dietary behaviours were investigated: positive salt use behaviour (SUB), meeting fruit and vegetable (F&V) recommendations and use of vegetable oil rather than animal fats in cooking. Generalized linear models were used to investigate the association between dietary behaviours and waist circumference (WC) and undiagnosed and diagnosed hypertension and diabetes. Interaction terms between sex and dietary behaviour were added to test for sex differences. Twenty-four thousand three hundred thirty-two participants were included. More females than males reported positive SUB (31.3 vs. 27.2% p-value < 0.001), yet less met F&V recommendations (13.2 vs. 14.8%, p-value< 0.05). The prevalence of reporting all three dietary behaviours in a positive manner was 2.7%, varying by country, but not sex. Poor SUB was associated with a higher prevalence of undiagnosed hypertension for females (13.1% vs. 9.9%, p-value = 0.04), and a higher prevalence of undiagnosed diabetes for males (2.4% vs. 1.5%, p-value = 0.02). Meeting F&V recommendations was associated with a higher prevalence of high WC (24.4% vs 22.6%, p-value = 0.01), but was not associated with undiagnosed or diagnosed hypertension or diabetes. Interventions to increase F&V intake and positive SUBs in the included countries are urgently needed. Dietary behaviours were not notably different between sexes. However, our findings were limited by the small proportion of the population reporting positive dietary behaviours, and further research is required to understand whether associations with CVD risk factors and interactions by sex would change as the prevalence of positive behaviours increases.

Sections du résumé

BACKGROUND
Cardiovascular diseases (CVD) are the leading causes of death for men and women in low-and-middle income countries (LMIC). The nutrition transition to diets high in salt, fat and sugar and low in fruit and vegetables, in parallel with increasing prevalence of diet-related CVD risk factors in LMICs, identifies the need for urgent action to reverse this trend. To aid identification of the most effective interventions it is crucial to understand whether there are sex differences in dietary behaviours related to CVD risk.
METHODS
From a dataset of 46 nationally representative surveys, we included data from seven countries that had recorded the same dietary behaviour measurements in adults; Bhutan, Eswatini, Georgia, Guyana, Kenya, Nepal and St Vincent and the Grenadines (2013-2017). Three dietary behaviours were investigated: positive salt use behaviour (SUB), meeting fruit and vegetable (F&V) recommendations and use of vegetable oil rather than animal fats in cooking. Generalized linear models were used to investigate the association between dietary behaviours and waist circumference (WC) and undiagnosed and diagnosed hypertension and diabetes. Interaction terms between sex and dietary behaviour were added to test for sex differences.
RESULTS
Twenty-four thousand three hundred thirty-two participants were included. More females than males reported positive SUB (31.3 vs. 27.2% p-value < 0.001), yet less met F&V recommendations (13.2 vs. 14.8%, p-value< 0.05). The prevalence of reporting all three dietary behaviours in a positive manner was 2.7%, varying by country, but not sex. Poor SUB was associated with a higher prevalence of undiagnosed hypertension for females (13.1% vs. 9.9%, p-value = 0.04), and a higher prevalence of undiagnosed diabetes for males (2.4% vs. 1.5%, p-value = 0.02). Meeting F&V recommendations was associated with a higher prevalence of high WC (24.4% vs 22.6%, p-value = 0.01), but was not associated with undiagnosed or diagnosed hypertension or diabetes.
CONCLUSION
Interventions to increase F&V intake and positive SUBs in the included countries are urgently needed. Dietary behaviours were not notably different between sexes. However, our findings were limited by the small proportion of the population reporting positive dietary behaviours, and further research is required to understand whether associations with CVD risk factors and interactions by sex would change as the prevalence of positive behaviours increases.

Identifiants

pubmed: 31928531
doi: 10.1186/s12937-019-0517-4
pii: 10.1186/s12937-019-0517-4
pmc: PMC6956488
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007433
Pays : United States

Références

Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Heart. 2019 Nov;105(22):1701-1708
pubmed: 31371439
Nutrients. 2015 Apr 10;7(4):2719-30
pubmed: 25867952
Lancet. 1993 Mar 6;341(8845):581-5
pubmed: 8094827
J Am Coll Cardiol. 2015 Oct 6;66(14):1538-1548
pubmed: 26429077
J Am Diet Assoc. 2010 May;110(5):736-45
pubmed: 20430135
BMJ Open. 2015 Sep 24;5(9):e008705
pubmed: 26408285
N Engl J Med. 2001 Jan 4;344(1):3-10
pubmed: 11136953
Lancet Glob Health. 2016 Oct;4(10):e695-703
pubmed: 27567348
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Public Health Nutr. 2018 Jan;21(1):5-17
pubmed: 28322183
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
Lancet Diabetes Endocrinol. 2019 Mar;7(3):231-240
pubmed: 30704950
Nutr Rev. 2012 Jan;70(1):3-21
pubmed: 22221213
N Engl J Med. 2006 Apr 13;354(15):1601-13
pubmed: 16611951
Lancet. 2017 Nov 4;390(10107):2037-2049
pubmed: 28864331
Am J Public Health. 2016 Sep;106(9):1624-30
pubmed: 27459454
Hypertension. 2008 Mar;51(3):629-34
pubmed: 18287345
Int J Environ Res Public Health. 2019 Apr 01;16(7):
pubmed: 30939754
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
BMJ. 2018 Nov 7;363:k4247
pubmed: 30404896
Sci Rep. 2018 Nov 16;8(1):16938
pubmed: 30446674
BMJ. 2013 Apr 03;346:f1325
pubmed: 23558162
Lancet. 2019 Aug 24;394(10199):652-662
pubmed: 31327566
J Nutr. 2019 Jul 1;149(7):1252-1259
pubmed: 31152660
Diabet Med. 2007 May;24(5):451-63
pubmed: 17470191
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
JAMA. 2016 Nov 8;316(18):1863-1864
pubmed: 27802482
Aust N Z J Public Health. 2007 Apr;31(2):105-12
pubmed: 17460999
Nutrition. 2005 Jan;21(1):39-50
pubmed: 15661477
BMC Res Notes. 2018 Jan 12;11(1):22
pubmed: 29329600
Obes Rev. 2019 Nov;20 Suppl 2:10-19
pubmed: 31099480
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Glob Health Action. 2015 Jan 22;8:25912
pubmed: 25623608
J Clin Hypertens (Greenwich). 2018 May;20(5):850-866
pubmed: 29722131
Prog Cardiovasc Dis. 2006 Sep-Oct;49(2):59-75
pubmed: 17046432
Am J Public Health. 2016 Sep;106(9):1616-23
pubmed: 27459449
BMJ. 2013 Apr 03;346:f1326
pubmed: 23558163
Curr Diab Rep. 2015 Sep;15(9):64
pubmed: 26209940
Public Health Nutr. 2009 May;12(5):729-31
pubmed: 19366466
Bull World Health Organ. 2013 Jan 1;91(1):57-63
pubmed: 23397351
Lancet. 2018 May 19;391(10134):2047-2058
pubmed: 29627161

Auteurs

Briar L McKenzie (BL)

The George Institute for Global Health, University of New South Wales, Sydney, Australia. bmckenzie@georgeinstitute.org.au.

Joseph Alvin Santos (JA)

The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Pascal Geldsetzer (P)

Division of Primary Care and Population Health, Department of Medicine, Stanford University, Stanford, USA.

Justine Davies (J)

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit, Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Jennifer Manne-Goehler (J)

Massachusetts General Hospital, Boston, USA.

Mongal Singh Gurung (MS)

Health Research and Epidemiology Unit, Ministry of Health, Thimphu, Bhutan.

Lela Sturua (L)

Non-Communicable Disease Department, National Center for Disease Control and Public Health, Petre Shotadze Tbilisi Medical Academy, Tbilisi, Georgia.

Gladwell Gathecha (G)

Division of Non-Communicable Diseases, Kenya Ministry of Health, Nairobi, Kenya.

Krishna K Aryal (KK)

DFID/NHSP3/MEOR, Abt Associates, Lalitpur, Nepal.

Lindiwe Tsabedze (L)

Ministry of Health, Mbabane, Eswatini.

Glennis Andall-Brereton (G)

Non-Communicable Diseases, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago.

Till Bärnighausen (T)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA.
Heidelberg Institute of Global Health (HIGH), Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Africa Health Research Institute (AHRI), Somkhele an Durban, Durban, South Africa.

Rifat Atun (R)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA.

Sebastian Vollmer (S)

Department of Economics and Centre for Modern Indian Studies, University of Göttingen, Göttingen, Germany.

Mark Woodward (M)

The George Institute for Global Health, University of New South Wales, Sydney, Australia.
The George Institute for Global Health, University of Oxford, Oxford, UK.
Department of Epidemiology, Johns Hopkins University, Baltimore, USA.

Lindsay M Jaacks (LM)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, USA.

Jacqui Webster (J)

The George Institute for Global Health, University of New South Wales, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH